During sleep, the iNAP sleep therapy system creates negative pressure within the oral cavity. The gentle vacuum pulls the tongue toward upper palate and pulls the soft palate forward. By stabilizing the tongue and soft tissues in a front position, patency of the upper airway near the pharynx can be maintained to provide unrestricted breathing and uninterrupted sleep.

The iF award-winning iNAP One sleep therapy system utilizes oral negative pressure technology to treat obstructive sleep apnea patients. The system includes an integrated console and a memory-fit oral interface.

The iNAP One provides an intuitive user interface with a built-in rechargeable battery and an easy-to-clean saliva container, making it a perfect travel companion.

Medical device certification

iNAP One (NP-R07-B/P) : 

CE certificated medical device (Class IIa)  

Australian Register of Therapeutic Goods Certificate : ARTG Identifier 312589  

Singapore HSA Medical device Registered : DE0502677

Malaysia Medical device certification : GB88527353317

Hong Kong Medical Devices List : HKMD No. 190095

The iNAP Lite sleep therapy system utilizes oral negative pressure technology to treat obstructive sleep apnea patients. The iNAP Lite is designed to provide a comfortable sleep experience for OSA patients. During sleep, the iNAP Lite creates a gentle vacuum within the oral cavity to stabilize the tongue and soft tissues and free the airway.

Unlike traditional CPAP machines, the iNAP Lite system works without a facial mask and instead uses a discreet soft oral interface and a pocket-sized and battery-powered console.

Medical device certification

iNAP Lite (NP-R03-K) : 

CE certificated medical device (Class IIa)

Taiwan Medical Devices Registration : MOHW-MD 006011  

Singapore HSA Medical device Registered : DE0502677

Malaysia Medical device certification : GB88527353317

Hong Kong Medical Devices List : HKMD No. 190095

SOMNICS® sleep therapy system and/or the use thereof in a method may be covered by one or more U.S. and/or foreign patents, including: US 7,918,222, US 8,567,406, US 8,616,208, US 9,138,342, US 9,387,117, US 9,339,620, US 10,080,855, US 10,149,782, US 10,149,783, US 10,159,595, US 10,166,140, US 8,122,889, US 8,656,922, US 8,667,970, US 9,241,825, US 9,655,768, US 8,505,540, US 9,610,190, US 8,074,656, US 8,122,890, US 8,701,672, US 8,387,620, US 9,387,118, US 9,387,119, US 10,117,773, US 8,402,973, US 8,573,223, US 8,979,823, US 9,549,795, US 9,101,495, US 9,375,541, US 9,763,759, US 9,483,792, US 15,376,368, EP 1862152, EP 2301490, EP 2347739, EP 2353555, EP 2868298, EP 2943170, EP 3095421, EP 2881090, EP 2209433, EP 2939634, EP 2605722, EP 0029004490001 RCD, EP 0029004490002 RCD, DE 2015121115024300, JP 5399534, JP 5727574, JP 5651488, JP 6002798, JP 6242914, JP 6346997, JP 6357573, JP 5404642, JP 5952817, JP 59944828, KR 10-1636436-0000, KR 10-1661639-0000, AU 2014205191, AU 2015399751, VN 3-2016-00928, VN 3-2016-00929, ID A00201601834, ID A00201601835, SG 30201602584Y, SG 30201602585X, TH 1602002134, TH 1602002135, IN 283925, IN 283926, CN 100506190, CN 102028574, CN 102133141, CN 102144946, CN 103989550, CN 103976814, CN 104000680, CN 104519841, CN 104540480, CN 104427958, CN 106170272, CN 205494125, CN 101917924, CN 103687568, CN 103140192, CN 103717181, and CN 201721828424.2 Other U.S. and foreign patent applications are pending.